Use and interpretation of HbA(1c) testing general practice. Implications for quality of care

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 60, Issue 5, 2000, Pages 349-356

  Skeie, S ^a   Thue, G ^a   Sandberg, S ^a  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Analytical variance; Biological variance; Case finding; Critical difference; Diabetes follow up; General practice; HbA1c; Laboratory quality; Quality of care

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; CASE FINDING; CASE REPORT; DIABETES MELLITUS; FEMALE; GENERAL PRACTICE; HEALTH CARE QUALITY; HUMAN; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; CLINICAL TRIAL; GENERAL PRACTITIONER; METABOLISM; MIDDLE AGED; NORWAY; QUESTIONNAIRE; STATISTICS;

AGED; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; NORWAY; PHYSICIANS, FAMILY; QUALITY ASSURANCE, HEALTH CARE; QUESTIONNAIRES;

EID: 0033626259     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655100750019251     Document Type: Article

References (26)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
2. Tests of glycemia in diabetes
3. Effect of long-term monitoring of glycosylated hemoglobin levels in insulin-dependent diabetes mellitus
4. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetes mellitus: A randomized prospective 6-year study
5. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes
6. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes
7. Standards of medical care for patients with diabetes mellitus (position statement)
8. The diabetes control and complications trial (DCCT). Design and methodologic considerations for the feasibility phase
9. Further development and automation of a high-pressure liquid chromatography method for the determination of glycosylated hemoglobins
10. Terminological problems around 'accuracy' and 'uncertainty'
11. Intraindividual variation of glycohemoglobin: Implications for interpretation and analytical goals
12. Generation and application of data on biological variation in clinical chemistry
13. A multisite physician's office laboratory evaluation of an immunological method for the measurement of HbA1c
14. A comparison of analytical goals for haemoglobin Alc assays derived using different strategies
15. Quality specifications for glycated hemoglobin Alc
16. The clinical usefulness of glucated haemoglobin in diabetes care evaluated by use of a medical technology assessment strategy
17. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
18. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation
19. Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited
20. Interlaboratory variation of GHb assays in Victoria, Australia
21. Problems in the assessment of glycemic contol in diabetes mellitus
22. Biologic variation of glycated hemoglobin. Implications for diabetes screening and monitoring
23. Comparison of studies on diabetic complications hampered by differences in GHb measurements
24. A clinical approach for the diagnosis of diabetes mellitus. An analysis using glycosylated hemoglobin levels
25. Will glycosylated haemoglobin replace the oral glucose-tolerance test?
26. Receiver operating characteristic analysis on fasting plasma glucose, HbA1c, and fructosamine on diabetes screening